Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience Tsuguo Naruke,

Slides:

Advertisements

Similar presentations

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Advertisements

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Minimally invasive esophagectomy

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

Thomas J. Birdas, MD, Richard P. M

Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis Amgad El-Sherif, MD, William E. Gooding, MS,

Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

A Japanese Lung Cancer Registry Study: Prognosis of 13,010 Resected Lung Cancers Hisao Asamura, MD, Tomoyuki Goya, MD, Yoshihiko Koshiishi, MD, Yasunori.

Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences Jean Deslauriers, MD, Jocelyn Grégoire,

Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.

Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,

Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non–small.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients Elizabeth A. David, MD, Stina W. Andersen, PhD,

Esophageal Resection for Cancer of the Esophagus: Long-Term Function and Quality of Life Allison J McLarty, MD, Claude Deschamps, MD, Victor F Trastek,

Ki-67 expression and prognosis for smokers with resected stage i Non–Small cell lung cancer Yukiko Haga, MD, Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi.

Surgical Management of Recurrent Thymic Epithelial Tumors: A Retrospective Analysis Based on the Japanese Nationwide Database Tetsuya Mizuno, MD, Meinoshin.

Lobe-specific extent of systematic lymph node dissection for non–small cell lung carcinomas according to a retrospective study of metastasis and prognosis

Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion Kenji Suzuki, MD, Hisao.

Age does not influence early and late tumor-related outcome for bronchogenic carcinoma Franziska Bernet, MD, Rudolf Brodbeck, MD, Marie-Olivier Guenin,

Thyroid lung metastasis diagnosed 47 years after thyroidectomy1

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Photodynamic Therapy for Early Stage Central Type of Lung Cancer

Thomas J. Birdas, MD, Richard P. M

Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic.

Influence of Cigarette Smoking on Survival and Tumor Invasiveness in Clinical Stage IA Lung Adenocarcinoma Ryo Maeda, MD, Junji Yoshida, MD, Genichiro.

Repke J Snijder, Aart Brutel de la Rivière, Hans J. J Elbers, Jules M

Use of Amiodarone After Major Lung Resection

The IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification.

Clinical Significance of Tumor-Infiltrating Lymphocytes in Lung Neoplasms Enrico Ruffini, MD, Sofia Asioli, MD, Pier Luigi Filosso, MD, Paraskevas Lyberis,

A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions Hisao Asamura, MD, Kenji Suzuki,

Radiologic Classification of Small Adenocarcinoma of the Lung: Radiologic-Pathologic Correlation and Its Prognostic Impact Kenji Suzuki, MD, Masahiko.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Predictors of Long-Term Survival After Resection of Esophageal Carcinoma With Nonregional Nodal Metastases Paul C. Lee, MD, Jeffrey L. Port, MD, Subroto.

Survival Differences by Gender for Resected Non-small Cell Lung Cancer: A Retrospective Analysis of 12,509 Cases in a Japanese Lung Cancer Registry Study

Results of surgical intervention for p-stage IIIA (N2) non–small cell lung cancer: Acceptable prognosis predicted by complete resection in patients with.

Prognostic assessment of 1310 patients with non–small-cell lung cancer who underwent complete resection from 1980 to 1993 Kunihiko Inoue, MDa, Masami.

Surgical Therapy for Bilateral Multiple Primary Lung Cancer

Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD

Short-course induction chemoradiotherapy with paclitaxel for stage III non-small-cell lung cancer Thomas W Rice, MD, David J Adelstein, MD, Jay P Ciezki,

Fluoroscopy-assisted thoracoscopic surgery after computed tomography-guided bronchoscopic barium marking Takehiro Okumura, MD, Haruhiko Kondo, MD, Kenji.

Pulmonary Resection for Lung Cancer in Octogenarians

Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung Marc Riquet, MD, Dominique Manac’h, MD, Françoise Le.

Pulmonary Resection in Patients Aged 80 Years or Over with Clinical Stage I Non-small Cell Lung Cancer: Prognostic Factors for Overall Survival and Risk.

Results of surgical treatment of non–small cell lung cancer: validation of the new postoperative pathologic tnm classification Jacek Jassem, MDa, Jan.

Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis Shun-ichi Watanabe, MD, Kenji Suzuki,

Multiple Primary Cancers or Multiple Metastases, That Is the Question

Clinicopathologic Features and Computed Tomographic Findings of 52 Surgically Resected Adenosquamous Carcinomas of the Lung Yukio Watanabe, MD, Koji.

Prognostic value of bronchiolo-alveolar carcinoma component of small lung adenocarcinoma Masahiko Higashiyama, MD, Ken Kodama, MD, Hideoki Yokouchi,

“Early” peripheral lung cancer: prognostic significance of ground glass opacity on thin- section computed tomographic scan Kenji Suzuki, MD, Hisao Asamura,

Immune-Modulating Vaccines in Non-small Cell Lung Cancer

Prognosis of Resected Non-Small Cell Lung Cancer Patients with Intrapulmonary Metastases Kanji Nagai, MD, Yasunori Sohara, MD, Ryosuke Tsuchiya, MD,

Subcategorization of Resectable Non-Small Cell Lung Cancer Involving Neighboring Structures Noriaki Sakakura, MD, Shoichi Mori, MD, Futoshi Ishiguro,

Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: The Japan Clinical.

Problems related to TNM staging: Patients with stage III non–small cell lung cancer Kotaro Kameyama, MD, Cheng-long Huang, MD, Dage Liu, MD, Taku Okamoto,

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Second operation for upper mediastinal lymphadenopathy after complete resection for cancer of the left lung Masami Sato, MDa, b, Teruaki Koike, MDa,

Neal S Goldstein, MD The Annals of Thoracic Surgery

Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer Steven M Keller, MD, Sudeshna Adak,

Nonanatomic prognostic factors in resected nonsmall cell lung carcinoma: the importance of perineural invasion as a new prognostic marker Adnan Sayar,

Japanese Lung Cancer Registry Study of 11,663 Surgical Cases in 2004: Demographic and Prognosis Changes Over Decade Noriyoshi Sawabata, MD, PhD, Etsuo.

Effectiveness of Postoperative Irradiation in Stage IIIA Non–Small Cell Lung Cancer According to Regression Tree Analyses of Recurrence Risks Timothy.

Left Pneumonectomy for Lung Cancer After Correction of Contralateral Partial Anomalous Pulmonary Venous Return Hiroyuki Sakurai, MD, Haruhiko Kondo,

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

A phase II single-institution study of neoadjuvant stage IIIA/B chemotherapy and radiochemotherapy in non-small cell lung cancer Andreas Granetzny, MD,

Induction Chemoradiation Is Not Superior to Induction Chemotherapy Alone in Stage IIIA Lung Cancer Asad A. Shah, MD, Mark F. Berry, MD, Ching Tzao, MD,

Survival and Prognosis After Pneumonectomy for Lung Cancer in the Elderly Yutaka Mizushima, Hirofumi Noto, Shigeki Sugiyama, Yoshinori Kusajima, Ryouhei.

Presentation transcript:

Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience Tsuguo Naruke, MD, Ryosuke Tsuchiya, MD, Haruhiko Kondo, MD, Hisao Asamura, MD The Annals of Thoracic Surgery Volume 71, Issue 6, Pages 1759-1764 (June 2001) DOI: 10.1016/S0003-4975(00)02609-6

Fig 1 Survival rates for 2,819 patients M0 group after resection of lung cancer according to pathological T (includes 3 patients with TX and 9 patients with T0). Differences between groups: T1 versus T2, p < 0.01; T2 versus T3, p < 0.01; T3 versus T4, p < 0.01. The Annals of Thoracic Surgery 2001 71, 1759-1764DOI: (10.1016/S0003-4975(00)02609-6)

Fig 2 Survival rates for 2,819 patients M0 group after resection of lung cancer, according to pathological N. Differences between groups: N0 versus N1, p < 0.01; N1 versus N2, p < 0.01; N2 versus N3, p < 0.01. The Annals of Thoracic Surgery 2001 71, 1759-1764DOI: (10.1016/S0003-4975(00)02609-6)

Fig 3 Survival rates for 3,043 patients after resection of lung cancer according to postoperative stage (includes 1 patient with occult carcinoma and 6 patients with stage 0). Differences between groups: stage IA versus stage IB, p < 0.01; stage IB versus stage IIA, not significant; stage IIA versus stage IIB, p < 0.01; stage IIB versus stage IIIA, p < 0.01; stage IIIA versus stage IIIB, p < 0.01; stage IIIB versus stage IV, p < 0.01. The Annals of Thoracic Surgery 2001 71, 1759-1764DOI: (10.1016/S0003-4975(00)02609-6)

Fig 4 Survival rates for 3,043 patients after resection of lung cancer according to clinical stage (includes 3 patients with occult carcinoma). Differences between groups: stage IA versus stage IB, p < 0.01; stage IB versus stage IIA, NS; stage IIA versus stage IIB, NS; stage IIB versus stage IIIA, p < 0.01; stage IIIA versus stage IIIB, p < 0.01; stage IIIB versus stage IV, NS. (NS = not significant.) The Annals of Thoracic Surgery 2001 71, 1759-1764DOI: (10.1016/S0003-4975(00)02609-6)

Fig 5 Survival rates for 3,043 patients after resection of lung cancer according to satellite nodule(s). Differences between groups: pm0 versus pm1, pm1 versus pm2, p < 0.01. (pm0 = no separate tumor nodule(s); pm1 = separate tumor nodule(s) in same lobe; pm2 = separate tumor nodule(s) in different lobe.) The Annals of Thoracic Surgery 2001 71, 1759-1764DOI: (10.1016/S0003-4975(00)02609-6)